VitaSpring Biomedical Co. Ltd. Share Price Other OTC
Equities
VSBC
US92851B1026
Biotechnology & Medical Research
Sales 2021 | 0.25 19.59 | Sales 2022 | 5.61 443.07 | Capitalization | 2.89B 228B |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | 1M 78.93M | EV / Sales 2021 | 2,936,169,226 x |
Net cash position 2021 | 45.4K 3.58M | Net Debt 2022 | 356K 28.13M | EV / Sales 2022 | 515,149,430 x |
P/E ratio 2021 |
-2,570
x | P/E ratio 2022 |
2,282
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 41.23% |
Managers | Title | Age | Since |
---|---|---|---|
Cheng Hsiang Kao
CEO | Chief Executive Officer | - | 20/01/20 |
Pao Chi Chu
CHM | Chairman | 70 | 20/01/20 |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | 20/01/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pao Chi Chu
CHM | Chairman | 70 | 20/01/20 |
1st Jan change | Capi. | |
---|---|---|
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |